FDA: PROC MIXED (‼) for ABE [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2021-09-17 17:15 (945 d 19:19 ago) – Posting: # 22581
Views: 2,569

Hi Mahmoud,

❝ I think that using proc mixed to fit RTR/TRR/RRT design is not suitable, because in most cases proc mixed produced Estimated G matrix is not positive definite.


❝ So proc GLM recommended by FDA and Emea is more appropriate in the Semi-replicated designs


Please read the entire thread again. The FDA does recommend PROC MIXED for ABE in all guidances.
That’s the problem.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,657 registered users;
80 visitors (0 registered, 80 guests [including 3 identified bots]).
Forum time: 12:34 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5